Transplant News and Research

RSS

ASH releases new guidelines for treating leukemia in adolescents and young adults

The American Society of Hematology (ASH) released guidelines on frontline management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), as well as the management of relapsed or refractory disease in this population.

12 Feb 2026

Case report examines potential cancer risks after mRNA vaccination

A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled "Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms."

12 Feb 2026

Trial highlights promising frontline therapy for blastic plasmacytoid dendritic cell neoplasm

Seventy-five percent of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) who were treated with the antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) had a complete response, according to new data from the Phase I/II multicenter international CADENZA trial led by researchers at The University of Texas MD Anderson Cancer Center.

11 Feb 2026

Artificial lung keeps patient alive after lung removal

Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.

5 Feb 2026

New immunotherapy could replace daily pills after kidney transplantation

A new study offers hope that kidney transplant patients could one day have a monthly treatment instead of multiple pills every day.

3 Feb 2026

"Artificial lungs" keep a patient alive until a double lung transplantation was available

Humans can't live without lungs. But Ankit Bharat's patient did for 48 hours.

29 Jan 2026

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Fecal microbiota transplants (FMT), can dramatically improve cancer treatment, suggest two groundbreaking studies published in the prestigious Nature Medicine journal.

28 Jan 2026

Prospera™ featured in landmark interventional study advancing lung transplant care

Natera, Inc., a global leader in cell-free DNA and precision medicine, today announced the publication of a new prospective clinical trial in Transplantation Direct. The study, which was conducted by The Ohio State University Wexner Medical Center (OSU-WMC), was initiated to explore whether donor-derived cell-free DNA (dd-cfDNA) surveillance, and specifically Prospera-guided monitoring, could reduce the number of invasive biopsies for patients following lung transplantation.

From Natera 27 Jan 2026

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell transplantation.

24 Jan 2026

Expert guidance on fecal microbiota transplantation in liver disease

The gut microbiota plays a crucial role in maintaining host health and liver function. Fecal microbiota transplantation (FMT), an emerging therapeutic modality, has demonstrated promising potential in the treatment of chronic liver diseases.

22 Jan 2026

Myosteatosis: An emerging predictor of outcomes in chronic liver disease

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of poor clinical outcomes across a spectrum of liver diseases.

22 Jan 2026

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), represent the most common chronic liver diseases in Western populations, driven largely by obesity and insulin resistance.

21 Jan 2026

Transplant News and Research

ASH releases new guidelines for treating leukemia in adolescents and young adults

Case report examines potential cancer risks after mRNA vaccination

Trial highlights promising frontline therapy for blastic plasmacytoid dendritic cell neoplasm

Artificial lung keeps patient alive after lung removal

New immunotherapy could replace daily pills after kidney transplantation

"Artificial lungs" keep a patient alive until a double lung transplantation was available

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Prospera™ featured in landmark interventional study advancing lung transplant care

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

Expert guidance on fecal microbiota transplantation in liver disease

Myosteatosis: An emerging predictor of outcomes in chronic liver disease

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

Medicaid tries new approach with sickle cell: Companies get paid only if costly gene therapies work

Study provides a new paradigm for managing transplant‑related immune complications

UK patients seeking surgery overseas are returning with complications the NHS must treat

Repurposed Alzheimer’s medication offers low-cost hope for sickle cell anemia

UC San Diego project aims to bioprint patient-specific transplantable human livers

Postoperative complications of medical tourism place growing financial burden on the NHS

Study reveals innate immune barriers to long-term pig kidney transplant survival

Scientists discover how stem cells navigate and repair brain damage after stroke

Industry Focus eBook - Cell biology (5th edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News